Home / Research / Manufacturers / Becton Dickinson & Co Medical-device intelligence
Becton Dickinson & Co: FDA clearances and recalls Research Becton Dickinson & Co in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
Names and coverage This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
Names observed in the source
Becton, Dickinson and Co. Becton Dickinson & Co Becton Dickinson & Co. Becton, Dickinson & CO Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.
Product codes in this company’s records Record activity in this scope 196 clearance records and 250 recall records in the covered releases, across 1 source company names and 77 product codes. Dated history runs from Apr 12, 13 to Aug 13, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 1 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 0 2 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 2 September 2026 0 0 October 2026 0 0
Product codes represented Code and FDA device name Clearances Recalls LON · System, Test, Automated, Antimicrobial Susceptibility, Short Incubation 107 29 JTN · Susceptibility Test Discs, Antimicrobial 7 32 MDB · System, Blood Culturing 2 18 JSO · Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar 2 13 FMI · Needle, Hypodermic, Single Lumen 11 0 NQX · System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen 0 11 PSZ · Devices Detecting Influenza A, B, And C Virus Antigens 8 3 JQP · Calculator/Data Processing Module, For Clinical Use 0 10 LSL · Dna-Reagents, Neisseria 8 2 JSI · Culture Media, Selective And Differential 1 8 JKA · Tubes, Vials, Systems, Serum Separators, Blood Collection 8 0 MJA · Susceptibility Test Powders, Antimycobacterial 2 6
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 446 matching records Device / record Company in FDA record Source Source date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMOXICILLIN (STREP) 0.0313 - 32 UG/ML K051692 · LONBecton, Dickinson & CO 510(k) Jul 14, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CLINDAMYCIN (STREP) 0.03125 -4 UG/ML K051272 · LONBecton, Dickinson & CO 510(k) Jul 11, 2005FDA decision date BD DIRECTIGEN EZ FLU A + B K042472 · PSZBecton, Dickinson & CO 510(k) Jul 7, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - LINEZOLID (STREP) 0.25 - 16UG/ML K051266 · LONBecton, Dickinson & CO 510(k) Jul 5, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM CEFEPIME (STREP) 0.0625-4UG/ML K051204 · LONBecton, Dickinson & CO 510(k) Jun 24, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GATIFLOXACIN (STREP) 0.0625 -8UG/ML K051183 · LONBecton, Dickinson & CO 510(k) Jun 21, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - ERYTHROMYCIN (STREP) 0.0156 - 4UG/ML K051109 · LONBecton, Dickinson & CO 510(k) Jun 15, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFTRIAXONE (STREP) 0.0625 - 4UG/ML K051138 · LONBecton, Dickinson & CO 510(k) Jun 3, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-MEROPENEM (STREP) 0.03125-2 UG/ML K050946 · LONBecton, Dickinson & CO 510(k) May 27, 2005FDA decision date BD PHONIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOTAXIME STREP (0.0625-4UG/ML) K050982 · LONBecton, Dickinson & CO 510(k) May 24, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-TRIMETHOPRIM-SULFAMETHOXAZOLE 0.0625/1.2-16/304 UG/ML K050865 · LONBecton, Dickinson & CO 510(k) May 20, 2005FDA decision date BD PHOENIXTM AUTOMATED MICROBIOLOGY SYSTEM - PENICILLIN (STREP) 0.156 -32 UG/ML K050780 · LONBecton, Dickinson & CO 510(k) May 12, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - TETRACYCLINE (STREP) 0.0625 - 16 UG/ML K050881 · LONBecton, Dickinson & CO 510(k) May 12, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, VANCOMYCIN (STREP) 0.0625 -32 UG/ML K050745 · LONBecton, Dickinson & CO 510(k) Apr 29, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM, LEVOFLOXACIN (STREP) 0.25-16 UG/ML K050747 · LONBecton, Dickinson & CO 510(k) Apr 29, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFAZOLIN (GP) 2-32 UG/ML K050555 · LONBecton, Dickinson & CO 510(k) Apr 14, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEPHALOTHIN (GP) 0.5-64 UG/ML K050400 · LONBecton, Dickinson & CO 510(k) Mar 22, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - CEFOTETAN (GN) 2-64 UG/ML K043458 · LONBecton, Dickinson & CO 510(k) Mar 15, 2005FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - AMPICILLIN-SULBACTAM (GP) 2-32 UG/ML K050089 · LONBecton, Dickinson & CO 510(k) Feb 28, 2005FDA decision date MODIFICATION TO BD FACSCANTO SYSTEM WITH BD FACSCANTO CLINICAL SOFTWARE K050191 · PERBecton, Dickinson & CO 510(k) Feb 22, 2005FDA decision date GEMIFLOXACIN, 5UG BBL SENSI-DISC K050062 · JTNBecton, Dickinson & CO 510(k) Feb 10, 2005FDA decision date BD ProbeTec ET Urine Processing Kit, 4x25, catalog 440454, packaged in a carton containing 4 storage bags identified as BD ProbeTec ET Urine Proc… Z-0455-05 · LSLBecton Dickinson & Co. Recall Feb 3, 2005FDA classification date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM -AMPICILLIN-SULBACTAM (GN) 0.5/0.25-32/16UG/ML K043389 · LONBecton, Dickinson & CO 510(k) Jan 21, 2005FDA decision date MODIFICATION TO BD ECLIPSE HYPODERMIC NEEDLE K043397 · FMIBecton, Dickinson & CO 510(k) Dec 29, 2004FDA decision date BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-PIPERACILLIN-TAZOBACTAM 0.5/4-128/4 UG/ML K042932 · LONBecton, Dickinson & CO 510(k) Dec 2, 2004FDA decision date
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗